Skip to main content Accessibility help
×
Hostname: page-component-7c8c6479df-r7xzm Total loading time: 0 Render date: 2024-03-28T17:36:09.636Z Has data issue: false hasContentIssue false

3 - Statistical approaches to rational biomarker selection

Published online by Cambridge University Press:  20 August 2009

Linda D. Sharples
Affiliation:
MRC Biostatistics Unit, Cambridge, UK
Andrew K. Trull
Affiliation:
Papworth Hospital, Cambridge
Lawrence M. Demers
Affiliation:
Pennsylvania State University
David W. Holt
Affiliation:
St George's Hospital Medical School, University of London
Atholl Johnston
Affiliation:
St. Bartholomew's Hospital and the Royal London School of Medicine and Dentistry
J. Michael Tredger
Affiliation:
Guy's, King's and St Thomas' School of Medicine
Christopher P. Price
Affiliation:
St Bartholomew's Hospital and Royal London School of Medicine & Dentistry
Get access

Summary

Introduction

This chapter aims to present and discuss some statistical approaches to identifying and validating the relationship between diagnostic markers and their clinical endpoints. Much of the work in this area has been developed in the context of clinical trials, although the principles extend naturally to cohort studies measuring exposure–end-point associations.

Informally, intermediate end-points or surrogates are laboratory measurements, X-ray results or other biological markers which are observed before the clinical end-point of interest occurs and which are useful in diagnosis, prognosis, monitoring patients or in the evaluation of the effects of an exposure or clinical intervention (E/I) to which patients are subjected (see Figure 3.1).

Motivation for the use of intermediate end-points or surrogates

Ideally, when studying the effects of an E/I, the appropriate outcome measure is the true clinical end-point of interest (CE), which is usually survival or the incidence of a clinical event. However, the CE may require invasive tests, be expensive, occur rarely or be temporally distant from the E/I. For example, in trials of cholesterol-lowering drugs, the fundamental end-point of interest may be death or development of coronary artery disease (CAD). Such a study may require the recruitment of thousands of patients followed up for many years. Clinicians, patients and funding bodies are keen to assess the effectiveness of promising new therapies quickly. This leads investigators to explore markers that may serve as intermediate end-points or surrogate end-points (IE/Ss) of the CE and which are more frequently occurring and temporally closer to the E/I.

Type
Chapter
Information
Biomarkers of Disease
An Evidence-Based Approach
, pp. 24 - 31
Publisher: Cambridge University Press
Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×